Single daily dose of cefodizime in patients with community-acquired pneumonia: an open-label, controlled, randomized study-Reference-Cited by-同舟云学术

Single daily dose of cefodizime in patients with community-acquired pneumonia: an open-label, controlled, randomized study

Published:1995-05 Issue:3 Volume:17 Page:413-424
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Del Palma Mario,Rocchi Danilo,Canepa Giorgio,Peri Angela,Cantone Valeria

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference39 articles.

1. In vitro and in vivo antibacterial activity of cefodizime;Hyodo;Chemotherapy (Japan),1988

2. In vivo antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin;Jones;Antimicrob Agents Chemother,1981

3. Comparative betalactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins;Jones;Infection,1982

4. Activité antibactérienne in vitro de la céfodizime (HR 221) sur 323 souches hospitalières de bacilles à gram négatif. Comparaison avec le céfotiam, la céfopérazone, le céfotétan et le céfotaxime;Le Noc;Pathol Biol,1985

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections;Clinical Microbiology and Antimicrobial Chemotherapy;2023

2. A Study Evaluating the Efficacy, Safety, and Tolerability of Ertapenem versus Ceftriaxone for the Treatment of Community‐Acquired Pneumonia in Adults;Clinical Infectious Diseases;2002-04-15

3. Traitement antibiotique des pneumonies communautaires de l'adulte – apport des nouvelles molécules ; place des traitements de durée abrégée ; données pharmaco-économiques;Médecine et Maladies Infectieuses;2001-01

4. Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia;Journal of Infection;1999-11